3.25Open3.25Pre Close0 Volume1 Open Interest7.50Strike Price0.00Turnover436.41%IV37.87%PremiumJan 17, 2025Expiry Date0.66Intrinsic Value100Multiplier22DDays to Expiry2.59Extrinsic Value100Contract SizeAmericanOptions Type-0.3259Delta0.0492Gamma2.10Leverage Ratio-0.0604Theta-0.0029Rho-0.69Eff Leverage0.0060Vega
Kezar Life Sciences Stock Discussion
SEC· just
Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences (KZR.US)$ ... for biotech...
recently he just sold.
$Kezar Life Sciences (KZR.US)$
$LumiraDx (LMDX.US)$
No comment yet